Say hello to MassDevice +3, a bite-sized view of the top three medtech stories of the day. This feature of MassDevice.com’s coverage highlights our 3 biggest and most influential stories from the day’s news to make sure you’re up to date on the headlines that continue to shape the medical device industry.
Medibio shares rose today on the Australian stock exchange after the company said it inked a deal with Medtronic.
“The non-binding MOU provides a framework under which Medibio and Medtronic will enter discussions around a proposed strategic agreement covering business opportunities and synergies across both companies,” Sydney-based Medibio said. Read more
Belgium-based additive manufacturer and 3D printing company Materialise said the FDA sent it a “not substantially equivalent” letter for its X-ray knee guide system, dooming its bid for 510(k) clearance from the federal safety watchdog.
The Materialise system is designed to help align total knee replacement components without MRI or CT scans, the company said. Read more
The 2-year pause on the medical device tax enacted last week is an opportunity to push through a full repeal of the 2.3% revenue tax, Rep. Erik Paulsen (R.-Minn.) told MassDevice.com.
“The next key step is just making sure the device tax repeal is permanent. So we essentially have a 2-year period to make sure that happens,” said Paulsen, who last month was tapped for the House Ways & Means Subcommittee on Health. Read more